Evidence map›Paper›PMID 39258548›Full record

ArticleNucleic acids research2024

HIV-1 usurps mixed-charge domain-dependent CPSF6 phase separation for higher-order capsid binding, nuclear entry and viral DNA integration.

Sooin Jang, Gregory J Bedwell, Satya P Singh, Hyun Jae Yu, Bjarki Arnarson, Parmit K Singh, Rajalingam Radhakrishnan, AidanDarian W Douglas, Zachary M Ingram, Christian Freniere and 9 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. G-Quadruplexes: Structural Diversity and Emerging Roles in Biomolecular Condensation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Review
  3. Article
  4. Mechanism of HIV-1 Capsid Rupture and Uncoating by Reverse Transcription.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sooin JangDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Gregory J BedwellDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Satya P SinghInstitute of Molecular Biophysics, Department of Biological Sciences, Florida State University, Tallahassee, FL 32304, USA.
Hyun Jae YuModel Development Section, Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, USA.
Bjarki ArnarsonDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Parmit K SinghDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Rajalingam RadhakrishnanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
AidanDarian W DouglasInstitute of Molecular Biophysics, Department of Biological Sciences, Florida State University, Tallahassee, FL 32304, USA.
Zachary M IngramDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Christian FreniereDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.
Onno AkkermansDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Stefan G SarafianosCenter for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Zandrea AmbroseDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Yong XiongDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.
Praju V AnekalMicRoN Core, Harvard Medical School, Boston, MA 02215, USA.
Paula Montero LlopisMicRoN Core, Harvard Medical School, Boston, MA 02215, USA.
Vineet N KewalRamaniModel Development Section, Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, USA.
Ashwanth C FrancisInstitute of Molecular Biophysics, Department of Biological Sciences, Florida State University, Tallahassee, FL 32304, USA.
Alan N EngelmanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0000-0002-9709-2591

Funding

Structural Biology CoreU54AI170855 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Alan N. Engelman · 2022 to 2026
$36.7M
Project 3. IntegrationU54AI170791 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Christopher R Aiken · 2022 to 2026
$30.6M
Nuclear Localization of HIV-1 Preintegration ComplexesR01AI052014 · NIAID · DANA-FARBER CANCER INSTITUTE · PI ENGELMAN, ALAN N. · 2003 to 2025
$11.4M
A multiscale approach for elucidating nuclear entry mechanisms of HIV-1 capsidR01AI162260 · NIAID · YALE UNIVERSITY · PI LIN, CHENXIANG, XIONG, YONG · 2021 to 2025
$3.5M
Predoctoral Program in BiophysicsT32GM149438 · NIGMS · YALE UNIVERSITY · PI Yong Xiong, Elsa Chui Ying Yan · 2023 to 2026
$2.6M
Characterization of full-lengh CPSF6 and its interaction with HIV capsidF31AI181652 · NIAID · YALE UNIVERSITY · PI FRENIERE, CHRISTIAN JOSEPH · 2024 to 2025
$68k
Gilead Research ScholarsNIAID NIH HHS F31 AI181652NIAID NIH HHS R01 AI052014NIAID NIH HHS R01 AI162260NIAID NIH HHS U54 AI170791NIAID NIH HHS U54 AI170855NIGMS NIH HHS T32 GM149438US National Institutes of Health R01AI052014
6 · The paper itself

Abstract

HIV-1 integration favors nuclear speckle (NS)-proximal chromatin and viral infection induces the formation of capsid-dependent CPSF6 condensates that colocalize with nuclear speckles (NSs). Although CPSF6 displays liquid-liquid phase separation (LLPS) activity in vitro, the contributions of its different intrinsically disordered regions, which includes a central prion-like domain (PrLD) with capsid binding FG motif and C-terminal mixed-charge domain (MCD), to LLPS activity and to HIV-1 infection remain unclear. Herein, we determined that the PrLD and MCD both contribute to CPSF6 LLPS activity in vitro. Akin to FG mutant CPSF6, infection of cells expressing MCD-deleted CPSF6 uncharacteristically arrested at the nuclear rim. While heterologous MCDs effectively substituted for CPSF6 MCD function during HIV-1 infection, Arg-Ser domains from related SR proteins were largely ineffective. While MCD-deleted and wildtype CPSF6 proteins displayed similar capsid binding affinities, the MCD imparted LLPS-dependent higher-order binding and co-aggregation with capsids in vitro and in cellulo. NS depletion reduced CPSF6 puncta formation without significantly affecting integration into NS-proximal chromatin, and appending the MCD onto a heterologous capsid binding protein partially restored virus nuclear penetration and integration targeting in CPSF6 knockout cells. We conclude that MCD-dependent CPSF6 condensation with capsids underlies post-nuclear incursion for viral DNA integration and HIV-1 pathogenesis.

Indexed as

CapsidCell NucleusDNA, ViralHIV-1mRNA Cleavage and Polyadenylation FactorsVirus IntegrationHEK293 CellsHeLa CellsHIV InfectionsHumansPhase SeparationProtein BindingProtein Domainscleavage factor Im, humanDNA, ViralmRNA Cleavage and Polyadenylation Factors

Identifiers

PMID39258548
PMCPMC11472059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.